Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
232
datasets available to search
ShareScore release 0.9.0
Dataset results
232 results for “uveal melanoma”
Ergolide Mediates Anti-Cancer Effects on Metastatic Uveal Melanoma Cells and Modulates their Cellular and Extracellular Vesicle proteomes
<p>Underlying dataset and extended dataset of the results described in the article "Ergolide Mediates Anti-Cancer Effects on Metastatic Uveal Melanoma Cells and Modulates their Cellular and Extracellular Vesicle proteomes".</p>
Dataset for "Overall Survival after Treatment for Metastatic Uveal Melanoma: A Systematic Review and Meta-Analysis"
<p>Raw data corresponding to the paper entitled: "<strong>Overall Survival after Treatment for Metastatic Uveal Melanoma: A Systematic Review and Meta-Analysis" </strong>published in <em>Melanoma Research</em> (2019) by Rantala <em>et al. </em></p>
Dataset for "Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group"
<p>Raw data corresponding to the paper entitled: "<strong>Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group</strong><strong>" </strong>published in <em>Am. J. Ophthalmol.</em> 2016 Aug;168:217-226 by Kivelä <em>et al.</em></p>
Immune Landscape and Gene Function Analysis of Uveal Melanoma Based on Focal Adhesion-Related Gene Typing
<p><strong>Figure legend</strong><strong>s</strong></p> <p><strong>Figure 1 Identification of focal adhesion gene clusters and immune analysis</strong></p> <p>(A) Relative changes in the area under the CDF curve. (B) Consensus clustering results, K=3. (C) Survival curves of different clusters. (D) ssGSEA heatmap showing differences in immune infiltration between clusters. (E) Expression levels of immune checkpoints in different clusters. (F) Violin plots of immune scores, stromal scores, ESTIMATE scores, and tumor purity scores.</p> <p> </p> <p><strong>Figure 2 GSEA pathway enrichment analysis</strong></p> <p> </p> <p><strong>Figure 3 PPI network related to DEGs between cluster 2 and clusters 1 and 3 and HUB gene selection</strong></p> <p>(A) Selection of DEGs between cluster 2 and clusters 1 and 3. (B) PPI network of DEGs between clusters. (C) Intersection analysis of the top 20 HUB genes in the PPI network using five algorithms.</p> <p> </p> <p><strong>Figure 4 Functional analysis of HUB genes in the interaction network and construction of co-expression network</strong></p> <p>(A) Heatmap showing the expression of HUB genes in cluster 2 and clusters 1 and 3. (B) GO functional enrichment analysis of HUB genes. (C) KEGG pathway enrichment analysis of HUB genes. (D) Construction of the co-expression network of HUB genes and their co-expressed genes.</p> <p> </p> <p><strong>Figure 5 Survival curves of patients corresponding to HUB genes at high and low expression levels</strong></p> <p> </p> <p><strong>Figure 6 Exploration of the correlation between HUB genes and drug sensitivity through CellMiner database</strong></p> <p> </p>
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
ClinicalTrials.gov study NCT03070392. IPD Sharing: Not stated. Countries: 14. Publications: 2.
Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance
ClinicalTrials.gov study NCT01100528. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
ClinicalTrials.gov study NCT02570308. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT04720417. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT04589832. IPD Sharing: NO. Countries: 1. Publications: 1.
Pembrolizumab in Treating Patients With Advanced Uveal Melanoma
ClinicalTrials.gov study NCT02359851. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT01585194. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
ClinicalTrials.gov study NCT01471054. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)
ClinicalTrials.gov study NCT01974752. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
ClinicalTrials.gov study NCT00506142. IPD Sharing: Not stated. Countries: 1. Publications: 1.
15-gene expression profile and PRAME as an integrated prognostic test for uveal melanoma: First report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)
Open the record for dataset details and reuse information.
Data from: Early genetic evolution of driver mutations in uveal melanoma
Open the record for dataset details and reuse information.
Death from causes other than Uveal Melanoma-Related in Patients with Uveal Melanoma and its associated cancers
<p>Patients with uveal melanoma die from cancer or other causes. Here, we list the other causes based on SEER 9.</p> <p>The record will be updated to refer to include the full article URL once published. There you can read the full methods.</p>
IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma
ClinicalTrials.gov study NCT04335890. IPD Sharing: NO. Countries: 1. Publications: 4.
Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma
ClinicalTrials.gov study NCT05889481. IPD Sharing: NO. Countries: 1. Publications: 14.
Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
ClinicalTrials.gov study NCT02849145. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.